SIMULTANEOUS ANALYSIS OF DIPHENHYDRAMINE AND A STABLE-ISOTOPE ANALOG (H-2(10) DIPHENHYDRAMINE USING CAPILLARY GAS-CHROMATOGRAPHY WITH MASS-SELECTIVE DETECTION IN BIOLOGICAL-FLUIDS FROM CHRONICALLY INSTRUMENTED PREGNANT EWES

被引:18
作者
TONN, GR
MUTLIB, A
ABBOTT, FS
RURAK, DW
AXELSON, JE
机构
[1] UNIV BRITISH COLUMBIA,FAC PHARMACEUT SCI,2146 E MALL,VANCOUVER V6T 1Z3,BC,CANADA
[2] UNIV BRITISH COLUMBIA,FAC MED,VANCOUVER V6T 1Z3,BC,CANADA
关键词
D O I
10.1002/bms.1200221103
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
This report describes both the synthesis of a stable isotope analog of the H-1 receptor antagonist diphenhydramine (DPHM), and the simultaneous quantitation of DPHM and a deuterated stable isotope analog of DPHM, viz. (H-2(10))DPHM in biological fluids from the chronically instrumented pregnant ewe. (H-2(10))DPHM was synthesized and purified, and both its structure and purity were verified. Biological samples were prepared for analysis using liquid-liquid extraction prior to capillary gas chromatography/mass spectrometry. The method employed electron impact ionization with selective ion monitoring of ions with m/z 165 for DPHM and m/z 173 for (H-2(10))DPHM. The minimal quantifiable concentration of DPHM and (H-2(10))DPHM from a 1.0 ml sample was 2.0 ng ml-1 in fetal and maternal plasma, fetal tracheal fluid and amniotic fluid. The method was validated from 2.0 ng ml-1 to 200.0 ng ml-1 for both DPHM and (H-2(10))DPHM in plasma, fetal tracheal fluid and amniotic fluid. Differences in the disposition between DPHM and (H-2(10))DPHM were not apparent during a control experiment in which both labeled and unlabeled DPHM were administered to a chronically instrumented fetal lamb. This method provides the required sensitivity and selectivity for the simultaneous quantitation of unlabeled and labeled DPHM during pharmacokinetic experiments conducted in near-term pregnant sheep.
引用
收藏
页码:633 / 642
页数:10
相关论文
共 26 条
[1]  
Battaglia F.C., 1986, INTRO FETAL PHYSL
[2]   SYNTHESIS OF TRITIUM LABELLED DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL) [J].
BLACKBURN, CE ;
OBER, RE .
JOURNAL OF LABELLED COMPOUNDS, 1967, 3 (03) :245-+
[3]   STABLE ISOTOPES IN CLINICAL PHARMACOKINETIC INVESTIGATIONS - ADVANTAGES AND DISADVANTAGES [J].
BROWNE, TR .
CLINICAL PHARMACOKINETICS, 1990, 18 (06) :423-433
[4]  
CARRUTHERS SG, 1978, CLIN PHARMACOL THER, V23, P375
[5]  
CHANG T, 1974, RES COMMUN CHEM PATH, V9, P391
[6]  
COOPER DG, 1990, COMPREHENSIVE MED CH, V3
[7]  
DOUGLAS WW, 1985, PHARM BASIS THERAPEU
[8]   THE PHARMACODYNAMICS OF DIPHENHYDRAMINE-INDUCED DROWSINESS AND CHANGES IN MENTAL PERFORMANCE [J].
GENGO, F ;
GABOS, C ;
MILLER, JK .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1989, 45 (01) :15-21
[9]   MEASUREMENT OF THERAPEUTIC CONCENTRATIONS OF TRICYCLIC ANTI-DEPRESSANTS IN SERUM [J].
GUPTA, R ;
MOLNAR, G .
DRUG METABOLISM REVIEWS, 1979, 9 (01) :79-97
[10]  
JACK DB, 1990, COMPREHENSIVE MED CH, V5